Search clinical trials for: mFOLFOX-6

Total 3000 results

Fudan University

Not yet recruiting

Cetuximab+mFOLFOX6 VS. mFOLFOX6 Alone in RAS/BRAF Wild Type Patients With High-Risk Resectable CRLM

Colorectal Cancer | Liver Metastases

China
NRG Oncology
National Cancer Institute (NCI); Natera, Inc.

Recruiting

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)

Stage III Colon Cancer

United States, Canada
Sirtex Medical

Completed

FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer (SIRFLOX)

Colorectal Cancer | Liver Metastases | Colorectal Carcinoma

United States, Israel, Australia, Belgium, New Zealand, Spain, Germany, Switzerland, Italy, France, Poland
Chungnam National University Hospital
Boryung Pharmaceutical Co., Ltd

Enrolling by invitation

Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer

Colon Cancer Stage III

Korea, Republic of
Spanish Cooperative Group for the Treatment of...

Completed

Safety and Efficacy Study of mFOLFOX-6 Plus Cetuximab for 8 Cycles Followed by mFOLFOX-6 Plus Cetuximab or Single Agent Cetuximab as Maintenance Therapy in Patients With Metastatic Colorectal Cancer and WT KRAS Tumours (MACRO-2)

Metastatic Colorectal Cancer

Spain
GlaxoSmithKline

Completed

Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, Oxaliplatin)

Neoplasms, Colorectal

India, United Kingdom
Eli Lilly and Company

Completed

A Study of Ramucirumab or Icrucumab in Colorectal Cancer

Rectal Cancer | Colon Cancer

United States, Canada
Five Prime Therapeutics, Inc.

Completed

A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer (FIGHT)

Gastric Cancer | Gastrointestinal Cancer | Gastrointestinal Cancer Metastatic

United States
Institut für Klinische Krebsforschung IKF GmbH...

Recruiting

Organ Preservation With Durvalumab-based Immunotherapy in Combination With Chemoradiation as Definitive Therapy for Early Stage Esophageal Adenocarcinoma With Indication for Radical Surgery

Esophagus Adenocarcinoma

Germany
Samsung Medical Center

Unknown

Study Investigating the Role of Oxaliplatin Duration in Modified FOLFOX-6 or CAPOX Regimen as Adjuvant Colon Cancer Therapy

Colon Cancer

Korea, Republic of
Hospital Universitari de Bellvitge
Instituto de Salud Carlos III

Terminated

Resection vs no Resection of the Primary in Colorectal Cancer With Unresectable Metastases (CCRe-IV)

Colonic Cancer | Unresectable Metastasis Originating in Colonic Cancer

Spain
Sun Yat-sen University

Recruiting

Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers

Colon Cancer Stage II | Colon Cancer Stage III

China
University of Kansas Medical Center
Merck Sharp & Dohme LLC

Active, not recruiting

Perioperative mFOLFOX Plus Pembrolizumab in Gastroesophageal Junction (GEJ) and Stomach Adenocarcinoma

Adenocarcinoma | Stomach Cancer | Gastro Esophageal Junction Cancer

United States
Five Prime Therapeutics, Inc.
Zai Lab (Shanghai) Co., Ltd.

Completed

A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer (FIGHT)

Gastric Cancer

United States, Spain, China, Italy, Korea, Republic of, Portugal, Taiwan, Japan, Turkey, France, Hungary, Thailand, Germany, Poland, Australia, Belgium, Romania, United Kingdom
MedImmune LLC

Withdrawn

Novel Oncology Therapies in Combination With Adjuvant Chemo in High-risk MSS-CRC

Microsatellite-stable Colorectal Cancer
Boehringer Ingelheim

Completed

BIBF 1120 Versus Bevacizumab in Metastatic Colorectal Cancer

Colorectal Neoplasms

Belgium, France, Germany, Italy, Spain
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Assessment of Ramucirumab Plus Paclitaxel as Switch MANteInance Versus Continuation of First-line Chemotherapy in Patients With Advanced HER-2 Negative Gastric or Gastroesophageal Junction Cancers (ARMANI)

Stomach Neoplasms

Italy
Institut für Klinische Krebsforschung IKF GmbH...

Active, not recruiting

Chemotherapy and Pembrolizumab, Followed by Pembrolizumab and Olaparib as Firstline Therapy in Her-2 Negative Gastric/GEJ Adenocarcinoma

Esophagogastric Adenocarcinoma

Germany
Amgen

Completed

PACCE: Panitumumab Advanced Colorectal Cancer Evaluation Study

Colorectal Cancer
Fox Chase Cancer Center

Suspended

Organ Preservation in Early Rectal Cancer Patients

Rectal Cancer

United States
Fudan University

Recruiting

Fruquintinib With mFOLFOX6/FOLFIRI as First-Line Therapy for Conversion Surgery in mCRC

Colorectal Cancer

China
University of Texas Southwestern Medical Center
Apexigen America, Inc.

Active, not recruiting

INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer

Locally Advanced Rectal Adenocarcinoma

United States
Liz-Anne Lewsley
AstraZeneca; NHS Greater Glasgow and Clyde; University of Glasgow

Not yet recruiting

A Trial of Durvalumab (MEDI 4736) in Combination With Extended Neoadjuvant Regimens in Rectal Cancer (PRIME-RT)

Rectal Cancer | Rectal Neoplasms | Rectal Adenocarcinoma
Jules Bordet Institute

Completed

Preoperative Chemosensitivity Testing to Predict Treatment Benefit in Adjuvant Stage III Colon Cancer (PePiTA)

Colon Cancer

Belgium
Canadian Cancer Trials Group

Completed

NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer

Rectal Cancer

United States, Canada
University of Saskatchewan

Terminated

FOLFIRI Alternate With FOLFOX in Untreated Metastatic Gastric and Esophageal Adenocarcinoma (LOGIC)

Metastatic Gastro-esophageal Adenocarcinoma

Canada
Yonsei University

Completed

Trastuzumab-pkrb Combined With Modified FOLFOX-6 in Biliary Tract Cancer Patients Progressed on First Line Therapy

HER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract Cancer

Korea, Republic of
Arcus Biosciences, Inc.

Completed

A Study to Evaluate Immunotherapy Combinations in Participants With Gastrointestinal Malignancies

Colorectal Cancer | GastroEsophageal Cancer

United States, Australia
B. Braun Melsungen AG

Completed

Safety Profile of Hydroxyethyl Starch

Plasma Volume Replacement

Malaysia, China
Gruppo Italiano per lo studio dei Carcinomi dell...
Mario Negri Institute for Pharmacological Research

Completed

FOLFOX-4 3months Versus 6 Months and Bevacizumab as Adjuvant Therapy for Patients With Stage II/III Colon Cancer (TOSCA)

Colon Cancer

Italy
Cuneyt M. Alper
National Institute on Deafness and Other Communication Disorders (NIDCD)

Completed

Trans-Middle-Ear Mucosal Gas Exchange Project 1, Specific Aim 1

Middle Ear Gas Exchange

United States
Sun Yat-sen University

Recruiting

Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria

Hepatocellular Carcinoma

China
Dartmouth-Hitchcock Medical Center

Completed

Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy

Gastric Cancer | Colorectal Cancer | Esophageal Cancer | Small Bowel Cancer | Appendix Cancer | Ampullary Cancer

United States
B. Braun Melsungen AG

Completed

Non-Interventional (Observational) Post-Authorization Safety Study of HES 130/0.42 in Paediatric Patients

Surgery

Germany, Austria, Czech Republic, Italy, Netherlands
Sixth Affiliated Hospital, Sun Yat-sen University

Recruiting

Adjuvant Chemotherapy in Clinical Local Advanced CRC Following Preoperational Therapies and pT0-3N0M0 Diagnosis (CANWATCH)

Colorectal Cancer | Adjuvant Chemotherapy

China
Cancer Institute and Hospital, Chinese Academy...
Xijing Hospital; Peking Union Medical College Hospital; Peking University Cancer... and other collaborators

Active, not recruiting

A Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer

Rectal Cancer

China
Immunovative Therapies, Ltd.
Mirror Biologics, Inc.

Recruiting

Immunotherapy for Advanced Liver Cancer (ALIVE)

Hepatocellular Carcinoma

Thailand, Malaysia
ART Fertility Clinics LLC

Recruiting

Impact of a Previous CS on the Ongoing Pregnancy Rate in Single Euploid Frozen Embryo Transfer (ET)

Infertility | Implantation

United Arab Emirates
Universitat Internacional de Catalunya

Recruiting

Effects of Using Mask During the 6-minute Walking Test in Times of COVID-19

Covid19 | Pulmonary Disease | Physical Disability

Spain
Celularity Incorporated

Completed

Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU

Diabetic Foot | Peripheral Arterial Disease

United States
Rui-hua Xu, MD, PhD

Not yet recruiting

A Phase II Study of Surufatinib Combined With PD-L1 and mFOLFOX6 as Second-line Treatment for Advanced PRAD

Advanced Pancreatic Cancer

China
Xu jianmin

Unknown

Cetuximab in Combination With Chemotherapy for the Treatment of Metastatic Colorectal Cancer

Neoplasm Metastasis | Liver Neoplasms | Colorectal Neoplasms

China
University of California, San Francisco
Tobacco Related Disease Research Program

Completed

An Extended Facebook Intervention for Young Sexual and Gender Minority Smokers (POP-6)

Smoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Disorder | Tobacco Use Cessation | Tobacco Dependence | Smoking, Tobacco | Smoking, Cigarette

United States
The Netherlands Cancer Institute

Terminated

Comparing Two Palliative Schemes of Radiotherapy for Head and Neck Cancer (COOPERATION)

Head and Neck Neoplasms

Netherlands
NYU Langone Health
Sanofi

Terminated

Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer

Pancreatic Cancer

United States
Adynxx, Inc.
National Institute on Drug Abuse (NIDA)

Withdrawn

Study to Evaluate a Preop Dose of Brivoligide Injection for Pain After Mastectomy in Patients With High PCS Scores

Pain, Postoperative
Peking University
Fudan University; Capital Medical University

Unknown

Study of Oxaliplatin, Calcium Folinate, and 5-Fluorouracil as Neoadjuvant Chemotherapy for Resectable Advanced Gastric Cancer

Stomach Neoplasms | Gastric Cancer

China
Fujian Cancer Hospital

Not yet recruiting

Second-line Surufatinib Combined With Chemotherapy in Advanced CRC

Advanced Colorectal Cancer
University Hospital, Tours

Not yet recruiting

The Effects of Mindfulness Meditation on Brain Metabolism in the Limbic Regions Studied by Magnetic Resonance Spectroscopy; Correlations With the Memory Performance and Episodic Metamemetory of Students. (MEMOREM)

Behavior
University of South Florida

Completed

Efficacy of MBSR Treatment of Cognitive Impairment Among Breast Cancer Survivors

Breast Cancer

United States

Search clinical trials for: mFOLFOX-6

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Panama

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations